The Use of a Tropism-Modified Measles Virus in Folate Receptor–Targeted Virotherapy of Ovarian Cancer

Kosei Hasegawa, Takafumi Nakamura, Mary Harvey, Yasuhiro Ikeda, Ann L. Oberg, Mariangela Figini, Silvana Canevari, Lynn C. Hartmann, Kah-Whye Peng

Clinical Cancer Research · 2006 · 83 citations · 37 references

DOIFull text

Open access

Abstract

A FR-exclusive ovarian cancer targeted oncolytic virus was generated and shown to be therapeutically effective, thus introducing a new modality for FR targeting and a candidate measles virus for clinical testing.

References

37